Patents by Inventor Klaus Heinrich

Klaus Heinrich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11646137
    Abstract: A method of forming a resistor circuit, the method comprising forming a first resistor comprising a first type of resistor, forming a second resistor comprising a second type of resistor, the first type of resistor being different from the second type of resistor and simultaneously doping a first part of the first resistor and a second part of the second resistor, the first resistor and the second resistor being configured such that doping of the first part of the first resistor and the second part of the second resistor defines a temperature coefficient of the first resistor and a temperature coefficient of the second resistor, wherein the temperature coefficient of the first resistor and the temperature coefficient of the second resistor have opposite signs.
    Type: Grant
    Filed: February 10, 2021
    Date of Patent: May 9, 2023
    Assignee: X-FAB GLOBAL SERVICES GMBH
    Inventors: Guido Janssen, Klaus Heinrich, Tillmann Walther, Xuezhou Cao, Jee Chang Lai
  • Patent number: 11499647
    Abstract: The invention relates to valve system for controlling a process fluid within a liquid processing system. The valve system comprises a valve arrangement, a pneumatic control system, and a connector unit. When the valve arrangement is connected to the connector unit, two or more valves are formed, such that the pneumatic control system controls an open/close or pressure control mode of the valves. A pump diaphragm system is disclosed, as well as a system for purifying a biological material that comprises the valve system or the pump diaphragm system. Also discloses are methods of using the valve system or the pump diaphragm system in a process for the purification of a biological material.
    Type: Grant
    Filed: December 9, 2019
    Date of Patent: November 15, 2022
    Assignee: Cytiva Sweden AB
    Inventors: Klaus Heinrich Gebauer, Stefan Sjolander
  • Publication number: 20220356959
    Abstract: The invention relates to valve system for controlling a process fluid within a liquid processing system. The valve system comprises a valve arrangement, a pneumatic control system, and a connector unit. When the valve arrangement is connected to the connector unit, two or more valves are formed, such that the pneumatic control system controls an open/close or pressure control mode of the valves. A pump diaphragm system is disclosed, as well as a system for purifying a biological material that comprises the valve system or the pump diaphragm system. Also discloses are methods of using the valve system or the pump diaphragm system in a process for the purification of a biological material.
    Type: Application
    Filed: June 23, 2022
    Publication date: November 10, 2022
    Inventors: Klaus Heinrich Gebauer, Stefan Sjolander
  • Patent number: 11427233
    Abstract: A particularly flexible method for automatically calibrating a wheel sensor includes using the wheel sensor to determine that a calibration must be carried out. The wheel sensor determines a point in time suitable for carrying out the calibration and the calibration itself is carried out by the wheel sensor at the determined point in time. A wheel sensor for carrying out the method is also provided.
    Type: Grant
    Filed: November 16, 2017
    Date of Patent: August 30, 2022
    Assignee: Siemens Mobility GmbH
    Inventors: Klaus Heinrich, Carsten Heise, Lutz-Helge Radwan, Eric Nannen
  • Publication number: 20220168851
    Abstract: The invention relates to a soldering material comprising an alloy that in addition to Sn (tin) as the major constituent, comprises 10 wt. % or less Ag (silver), 10 wt. % or less Bi (bismuth), 10 wt. % or less Sb (antimony) and 3 wt. % or less Cu (copper). Furthermore, the invention relates to a soldering material comprising a plurality of soldering components with such alloy compositions and contents in the soldering material that on fusing the soldering components an alloy is formed that comprises Sn, Ag, Bi, Sb and Cu in the abovementioned alloy contents.
    Type: Application
    Filed: February 18, 2022
    Publication date: June 2, 2022
    Inventors: Hans-Jurgen Albrecht, Gunnar Petzold, Klaus Wilke, Klaus Heinrich Georg Bartl, Hector Andrew Steen, Klaus Muller, Werner Kruppa, Mathias Nowottnick, Klaus Wittke
  • Publication number: 20220135693
    Abstract: The present invention provides novel humanized anti-human CCR7 antibodies and compositions comprising such antibodies. The antibodies and compositions are useful in the treatment of a cancer of which the tumour cells express a CCR7 receptor, in the treatment of inflammatory conditions, conditions or complications arising from tissue or organ transplantations, and conditions or complications arising from or associated with fibrosis. The invention further provides nucleic acid molecules encoding the anti-CCR7 antibodies, cells expressing the anti-CCR7 antibodies and methods for producing the anti-CCR7 antibodies.
    Type: Application
    Filed: January 18, 2022
    Publication date: May 5, 2022
    Applicant: PepMab B.V.
    Inventors: Jaap Willem Back, Ronald Boshuizen, Wouter Cornelis Puijk, Johan Turkstra, Klaus Heinrich Schwamborn
  • Patent number: 11285569
    Abstract: The invention relates to a soldering material comprising an alloy that in addition to Sn (tin) as the major constituent, comprises 10 wt. % or less Ag (silver), 10 wt. % or less Bi (bismuth), 10 wt. % or less Sb (antimony) and 3 wt. % or less Cu (copper). Furthermore, the invention relates to a soldering material comprising a plurality of soldering components with such alloy compositions and contents in the soldering material that on fusing the soldering components an alloy is formed that comprises Sn, Ag, Bi, Sb and Cu in the abovementioned alloy contents.
    Type: Grant
    Filed: August 2, 2019
    Date of Patent: March 29, 2022
    Assignees: Henkel AG & Co. KGaA, Heraeus Duetschland GmbH & Co. KG, Alpha Assembly Solutions Inc.
    Inventors: Hans-Jurgen Albrecht, Gunnar Petzold, Klaus Wilke, Klaus Heinrich Georg Bartl, Hector Andrew Hamilton Steen, Klaus Muller, Werner Kruppa, Mathias Nowottnick, Klaus Wittke
  • Patent number: 11254749
    Abstract: The present invention provides novel humanized anti-human C—C chemokine receptor type 7 (CCR7) antibodies and compositions comprising such antibodies. The antibodies and compositions are useful in the treatment of a cancer of which the tumour cells express a CCR7 receptor, in the treatment of inflammatory conditions, conditions or complications arising from tissue or organ transplantations, and conditions or complications arising from or associated with fibrosis. The invention further provides nucleic acid molecules encoding the anti-CCR7 antibodies, cells expressing the anti-CCR7 antibodies and methods for producing the anti-CCR7 antibodies.
    Type: Grant
    Filed: March 10, 2020
    Date of Patent: February 22, 2022
    Assignee: PepMab B.V.
    Inventors: Jaap Willem Back, Ronald Boshuizen, Wouter Cornelis Puijk, Johan Turkstra, Klaus Heinrich Schwamborn
  • Patent number: 11131299
    Abstract: The invention relates to a pump having a piezo diaphragm transducer arranged at a pump body of the pump, and to a method for producing a pump, wherein a piezo diaphragm transducer is mounted to a pump body, wherein the method, among other things, has providing a piezoceramic layer. In accordance with the invention, at least one piezo element is diced from the piezoceramic layer so that the at least one piezo element has a regular polygon shape having at least six corners. In addition, the method has forming the piezo diaphragm transducer by mounting the piezo element to a pump diaphragm.
    Type: Grant
    Filed: January 30, 2017
    Date of Patent: September 28, 2021
    Assignee: Fraunhofer-Gesellschaft zur Foerderung der angewandten Forschung e.V.
    Inventors: Martin Richter, Yuecel Congar, Klaus Heinrich, Waltraud Hell, Martin Wackerle
  • Publication number: 20210249163
    Abstract: A method of forming a resistor circuit, the method comprising forming a first resistor comprising a first type of resistor, forming a second resistor comprising a second type of resistor, the first type of resistor being different from the second type of resistor and simultaneously doping a first part of the first resistor and a second part of the second resistor, the first resistor and the second resistor being configured such that doping of the first part of the first resistor and the second part of the second resistor defines a temperature coefficient of the first resistor and a temperature coefficient of the second resistor, wherein the temperature coefficient of the first resistor and the temperature coefficient of the second resistor have opposite signs.
    Type: Application
    Filed: February 10, 2021
    Publication date: August 12, 2021
    Inventors: Guido JANSSEN, Klaus HEINRICH, Tillmann WALTHER, Xuezhou CAO, Jee Chang LAI
  • Publication number: 20210242532
    Abstract: The invention relates to a thermoplastic polymer-based battery separator, which contains a compound of formula R (OR1)n(COOMx+1/x)m. In said formula, R represents a non-aromatic hydrocarbon group comprising between 10 and 4,200 carbon atoms, which can be interrupted by oxygen atoms, R1 represents H, —(CH2)kCOOMx+1/x or —(CH2)k—SO3Mx+1/x, whereby k stands for 1 or 2, M represents an alkali or earth alkaline metal ion, H+ or NH4+, whereby not all variables of M are defined simultaneously as H+, n stands for 0 or 1, m stands for 0 or a whole number from 10 to 1,400 and x stands for 1 or 2. The ratio of oxygen atoms to carbon atoms in the compound according to the aforementioned formula ranges between 1:1.5 and 1:30 and n and m cannot simultaneously represent zero.
    Type: Application
    Filed: April 22, 2021
    Publication date: August 5, 2021
    Inventors: Jorg Deiters, Klaus Heinrich Ihmels
  • Patent number: 11018399
    Abstract: The invention relates to a thermoplastic polymer-based battery separator, which contains a compound of formula R (OR1)n(COOMx+1/x)m. In said formula, R represents a non-aromatic hydrocarbon group comprising between 10 and 4,200 carbon atoms, which can be interrupted by oxygen atoms, R1 represents H, —(CH2)kCOOMx+1/x or —(CH2)k—SO3Mx+1/x, whereby k stands for 1 or 2, M represents an alkali or earth alkaline metal ion, H+ or NH4+, whereby not all variables of M are defined simultaneously as H+, n stands for 0 or 1, m stands for 0 or a whole number from 10 to 1,400 and x stands for 1 or 2. The ratio of oxygen atoms to carbon atoms in the compound according to the aforementioned formula ranges between 1:1.5 and 1:30 and n and m cannot simultaneously represent zero.
    Type: Grant
    Filed: December 12, 2017
    Date of Patent: May 25, 2021
    Assignee: Daramic, LLC
    Inventors: Jorg Deiters, Klaus Heinrich Ihmels
  • Patent number: 11009529
    Abstract: A high-voltage sensing device providing full galvanic isolation between a high-voltage domain and a low-voltage domain, wherein the circuit topology of the device resembles that of a Wheatstone bridge, the Wheatstone bridge employing at least one voltage-controlled semiconductor resistor, wherein the circuit also comprises a reference source connected directly to the Wheatstone bridge and the device comprises a number of shielding structures to electrically isolate the high-voltage domain from the low-voltage domain.
    Type: Grant
    Filed: September 26, 2017
    Date of Patent: May 18, 2021
    Assignee: X-FAB SEMICONDUCTOR FOUNDRIES GMBH
    Inventors: Klaus Heinrich, Hartmut Liebing, Andreas Roth, Stefan Eisenbrandt, Andreas Ott, Bruno Boury
  • Publication number: 20200362043
    Abstract: The present invention provides novel humanized anti-human CCR7 antibodies and compositions comprising such antibodies. The antibodies and compositions are useful in the treatment of a cancer of which the tumour cells express a CCR7 receptor, in the treatment of inflammatory conditions, conditions or complications arising from tissue or organ transplantations, and conditions or complications arising from or associated with fibrosis. The invention further provides nucleic acid molecules encoding the anti-CCR7 antibodies, cells expressing the anti-CCR7 antibodies and methods for producing the anti-CCR7 antibodies.
    Type: Application
    Filed: March 10, 2020
    Publication date: November 19, 2020
    Applicant: PepMab B.V.
    Inventors: Jaap Willem Back, Ronald Boshuizen, Wouter Cornelis Puijk, Johan Turkstra, Klaus Heinrich Schwamborn
  • Publication number: 20200232576
    Abstract: The invention relates to valve system for controlling a process fluid within a liquid processing system. The valve system comprises a valve arrangement, a pneumatic control system, and a connector unit. When the valve arrangement is connected to the connector unit, two or more valves are formed, such that the pneumatic control system controls an open/close or pressure control mode of the valves. A pump diaphragm system is disclosed, as well as a system for purifying a biological material that comprises the valve system or the pump diaphragm system. Also discloses are methods of using the valve system or the pump diaphragm system in a process for the purification of a biological material.
    Type: Application
    Filed: December 9, 2019
    Publication date: July 23, 2020
    Applicant: GE Healthcare Bio-Sciences AB
    Inventors: Klaus Heinrich Gebauer, Stefan Sjolander
  • Patent number: 10640565
    Abstract: The present invention provides novel humanized anti-human C-C chemokine receptor type 7 (CCR7) antibodies and compositions comprising such antibodies. The antibodies and compositions are useful in the treatment of a cancer of which the tumour cells express a CCR7 receptor, in the treatment of inflammatory conditions, conditions or complications arising from tissue or organ transplantations, and conditions or complications arising from or associated with fibrosis. The invention further provides nucleic acid molecules encoding the anti-CCR7 antibodies, cells expressing the anti-CCR7 antibodies and methods for producing the anti-CCR7 antibodies.
    Type: Grant
    Filed: August 10, 2016
    Date of Patent: May 5, 2020
    Assignee: PepMab B.V.
    Inventors: Jaap Willem Back, Ronald Boshuizen, Wouter Cornelis Puijk, Johan Turkstra, Klaus Heinrich Schwamborn
  • Publication number: 20200023472
    Abstract: The invention relates to a soldering material comprising an alloy that in addition to Sn (tin) as the major constituent, comprises 10 wt. % or less Ag (silver), 10 wt. % or less Bi (bismuth), 10 wt. % or less Sb (antimony) and 3 wt. % or less Cu (copper). Furthermore, the invention relates to a soldering material comprising a plurality of soldering components with such alloy compositions and contents in the soldering material that on fusing the soldering components an alloy is formed that comprises Sn, Ag, Bi, Sb and Cu in the abovementioned alloy contents.
    Type: Application
    Filed: August 2, 2019
    Publication date: January 23, 2020
    Inventors: Hans-Jurgen Albrecht, Gunnar Petzold, Klaus Wilke, Klaus Heinrich Georg Bartl, Hector Andrew Hamilton Steen, Klaus Muller, Werner Kruppa, Mathias Nowottnick, Klaus Wittke
  • Patent number: D909245
    Type: Grant
    Filed: August 8, 2019
    Date of Patent: February 2, 2021
    Assignee: FCA ITALY S.p.A.
    Inventor: Klaus Heinrich Busse
  • Patent number: D909246
    Type: Grant
    Filed: August 8, 2019
    Date of Patent: February 2, 2021
    Assignee: FCA ITALY S.p.A.
    Inventor: Klaus Heinrich Busse
  • Patent number: D1002434
    Type: Grant
    Filed: November 4, 2021
    Date of Patent: October 24, 2023
    Assignee: FCA ITALY S.p.A.
    Inventor: Klaus Heinrich Busse